A stereoselective synthesis of (R)-(-)-rolipram from L-glutamic acid i
s described. The key step is a stereoselective Michael addition of an
arylcuprate to a modified pyroglutamic derivative which acts as the te
mplate to induce the stereoselectivity. Facile manipulation of the ena
ntiomerically pure Michael product afforded the expected therapeutic a
gent.